TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Cancer Genetics, Inc. (NASDAQ: CGIX) Investor Securities Class Action Lawsuit 04/05/2018

  • If you purchased shares of Cancer Genetics, Inc. (NASDAQ: CGIX), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

February 25, 2020 - The court granted the defendants' motion to dismiss. The case was dismissed with prejudice. December 31, 2018 - A motion to dismiss the amended complaint was filed. October 30, 2018 - An amended complaint was filed. April 5, 2018 - An investor in shares of Cancer Genetics, Inc. (NASDAQ: CGIX) filed a lawsuit in the U.S. District Court for the District of New Jer...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: